American International Group Inc. Has $1.66 Million Stake in Balchem Co. (BCPC)

American International Group Inc. decreased its position in Balchem Co. (NASDAQ:BCPC) by 19.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 20,258 shares of the basic materials company’s stock after selling 4,976 shares during the period. American International Group Inc.’s holdings in Balchem were worth $1,656,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of BCPC. Schwab Charles Investment Management Inc. grew its stake in shares of Balchem by 10.9% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 170,119 shares of the basic materials company’s stock valued at $13,712,000 after buying an additional 16,782 shares during the period. Congress Asset Management Co. MA grew its stake in shares of Balchem by 6.3% in the 4th quarter. Congress Asset Management Co. MA now owns 47,904 shares of the basic materials company’s stock valued at $3,861,000 after buying an additional 2,837 shares during the period. Comerica Bank grew its stake in shares of Balchem by 10.3% in the 4th quarter. Comerica Bank now owns 42,426 shares of the basic materials company’s stock valued at $3,399,000 after buying an additional 3,964 shares during the period. Aperio Group LLC grew its stake in shares of Balchem by 10.3% in the 4th quarter. Aperio Group LLC now owns 10,482 shares of the basic materials company’s stock valued at $845,000 after buying an additional 975 shares during the period. Finally, SeaCrest Wealth Management LLC purchased a new stake in shares of Balchem in the 4th quarter valued at approximately $113,000. 87.38% of the stock is owned by institutional investors and hedge funds.

Balchem opened at $96.43 on Friday, Marketbeat reports. Balchem Co. has a 1-year low of $70.23 and a 1-year high of $98.98. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.16 and a quick ratio of 1.48. The company has a market capitalization of $3.12 billion, a PE ratio of 35.84 and a beta of 0.94.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Friday, May 4th. The basic materials company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.06. The business had revenue of $161.41 million during the quarter. Balchem had a net margin of 15.18% and a return on equity of 14.50%.

Several analysts have recently weighed in on the stock. BidaskClub raised shares of Balchem from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, April 11th. Pivotal Research raised shares of Balchem from a “sell” rating to a “hold” rating and set a $85.00 price target for the company in a research note on Monday, May 7th. Finally, Vertical Group cut shares of Balchem from a “buy” rating to a “hold” rating in a research note on Monday, May 7th. They noted that the move was a valuation call.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply